Washington,SANA-A new study highlighted the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing them as miracle drugs.
The study published in Nature Medicine is marking a milestone in the study of new-generation weight-loss drugs such as Ozempic, Wegovy and Mounjaro, which have already somewhat revolutionised the fight against obesity.
GLP-1 medications, which first came on the market about a decade ago, combat obesity and related conditions by mimicking the function of a hormone that secretes insulin, slows down the emptying of the stomach and suppresses appetite.
Multiple studies had already shown that their benefits might go beyond weight loss and diabetes.
Those studies showed that patients taking GLP-1 medication fared better against a wide range of health problems such as dementia, cardiovascular diseases or alcohol addiction.
The GLP-1 patients had “a lower risk of drug use, psychological or convulsive disorders, neurocognitive disorders, including Alzheimer’s disease and other types of dementia, coagulation and cardiometabolic disorders, infectious diseases and various respiratory pathologies,” the study found.
Nature Medicine
Khadega/Nora
